{"id":"CHEMBL1006","canonicalSmiles":"NCCCNCCSP(=O)(O)O","inchiKey":"JKOQGQFVAUAYPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIFOSTINE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amifostine","Ethyol"],"synonyms":["Amifostine","Amifostine anhydrous","Amifostine disulfide","Amifostine trihydrate","Ethiofos","Ethiofos anhydrous","Gammaphos","NSC-296961","NSC-758236","WR-2721","WR-2721 TRIHYDRATE","YM-08310"],"crossReferences":{"DailyMed":["amifostine"],"PubChem":["11110755","144203628","147094","170465179","50105748","90341753"],"Wikipedia":["Amifostine"],"drugbank":["DB01143"],"chEBI":["2636"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 4 approved and 35 investigational indications."}
{"id":"CHEMBL1026","canonicalSmiles":"CS(=O)(=O)O.Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1","inchiKey":"CVKUMNRCIJMVAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOLDOPAM MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL588","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corlopam","Fenoldopam mesylate"],"synonyms":["Fendolopam mesylate","Fenoldopam mesilate","Fenoldopam mesylate","Fenoldopam methanesulfonate","NSC-759860","SK&F 82526-J","SK&F-82526J","SK-82526-J"],"crossReferences":{"DailyMed":["fenoldopam%20mesylate"],"PubChem":["49681595"]},"linkedTargets":{"rows":["ENSG00000184845"],"count":1},"linkedDiseases":{"rows":["HP_0001919","EFO_0001645","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for hypertension and has 1 investigational indication."}
{"id":"CHEMBL1077896","canonicalSmiles":"CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C","inchiKey":"ZKMNUMMKYBVTFN-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROPIVACAINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ropivacaine","Ropivicaine","TLC-590","TLC590","Tlc590"],"crossReferences":{"DailyMed":["ropivacaine%20hydrochloride"],"PubChem":["26758019"],"Wikipedia":["Ropivacaine"],"drugbank":["DB00296"],"chEBI":["8890"]},"childChemblIds":["CHEMBL1889140"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["HP_0003470","EFO_0003869","MONDO_0041052","EFO_0000275","HP_0030838","EFO_0004698","EFO_1001909","EFO_0003964","EFO_0003931","EFO_1001366","EFO_0004253","EFO_1000786","MONDO_0008903","EFO_0004616","EFO_1000652","EFO_0009552","EFO_0009620","EFO_0000400","EFO_1001250","EFO_0005762","HP_0000016","HP_0200042","HP_0012532","MONDO_0008170","MONDO_0008315","HP_0002027","EFO_0000546","HP_0003040","EFO_0004209","EFO_0000432","EFO_0005251","EFO_1001792","EFO_0004214","MONDO_0007254","EFO_0008553","MONDO_0001056","MONDO_0005277","EFO_0009507","EFO_0009514","HP_0001385","HP_0030834","HP_0002017","EFO_0004143","HP_0001822","EFO_0000616","EFO_0009508","EFO_0006859","EFO_0001358","EFO_0009387","EFO_0003843","EFO_1000941","EFO_0000311","HP_0000713","EFO_0007149","HP_0030839","HP_0000138","EFO_0005611","MONDO_0001572","MONDO_0005178","HP_0000023","EFO_0009615","EFO_0004710"],"count":62},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for pain and has 27 investigational indications."}
{"id":"CHEMBL1086863","canonicalSmiles":"OC[C@H]1O[C@H](O)[C@H](F)[C@@H](O)[C@@H]1O","inchiKey":"ZCXUVYAZINUVJD-UKFBFLRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDEOXYGLUCOSE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fludeoxyglucose"],"crossReferences":{"DailyMed":["fludeoxyglucose%20f-18"],"drugbank":["DB04282"],"chEBI":["49132"]},"childChemblIds":["CHEMBL1092067"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 32 investigational indications."}
{"id":"CHEMBL1163085","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NC(=O)[C@@H](N)Cc2ccc(O)cc2)[C@@H](O)[C@H]1O","inchiKey":"MJZAZMKENKZBAJ-QTOWJTHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1163085","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03325"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1165268","canonicalSmiles":"O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I","inchiKey":"FFINMCNLQNTKLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODIPAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cholografin"],"synonyms":["Adipiodone","Iodipamide","NSC-757423"],"crossReferences":{"PubChem":["11112428","144207053","170464888","47193872"],"Wikipedia":["Adipiodone"],"drugbank":["DB04711"]},"childChemblIds":["CHEMBL3989806","CHEMBL2104843","CHEMBL1200504","CHEMBL1200350"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1184904","canonicalSmiles":"C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)N2","inchiKey":"OAKGNIRUXAZDQF-TXHRRWQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETASPIMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPI-504","Retaspimycin"],"crossReferences":{"drugbank":["DB05626"],"chEBI":["71975"]},"childChemblIds":["CHEMBL377559"],"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["MONDO_0008903","Orphanet_44890","EFO_0000673","MONDO_0007254","EFO_0001378","EFO_0000305","EFO_0003085","EFO_0003060","EFO_0002617","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1186894","canonicalSmiles":"CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O","inchiKey":"VJZITPJGSQKZMX-XDPRQOKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMRUBICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amrubicin"],"crossReferences":{"Wikipedia":["Amrubicin"],"drugbank":["DB06263"]},"childChemblIds":["CHEMBL481958"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000576","EFO_1000581","MONDO_0008903","EFO_0000702","MONDO_0007254","EFO_0001378","EFO_1001968","MONDO_0001187"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1200420","canonicalSmiles":"Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl","inchiKey":"PLYSCVSCYOQVRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIDAZOLAM HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL655","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Buccolam","Dormicum","Hypnovel","Midazolam hydrochloride","Midazolam hydrochloride preservative free","Midozalam hydrochloride","Rocam","Seizalam","Versed"],"synonyms":["Midazolam hcl","Midazolam hydrochloride","Midazolam hydrochloride civ","NSC-751451","RO 21-3981/003","RO-213981001","Ro-213981-003","SHP-615","SHP615"],"crossReferences":{"DailyMed":["midazolam%20hydrochloride"],"PubChem":["144206166","170465015","49731994"]},"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0008526","EFO_0000616","EFO_0007623","EFO_0006834","MONDO_0002009","EFO_1001454","Orphanet_3389","EFO_0000618","EFO_0009267","EFO_0000274","EFO_1001884","EFO_0000662","EFO_0000546","HP_0100543","EFO_0000289","MONDO_0002050","HP_0002045","EFO_0007634","EFO_0005611","MONDO_0005148"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200472","canonicalSmiles":"Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21","inchiKey":"IKMPWMZBZSAONZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUAZEPAM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doral"],"synonyms":["NSC-309702","Quazepam","Quazepam civ","SCH 16134","SCH-16134"],"crossReferences":{"DailyMed":["quazepam"],"Wikipedia":["Quazepam"],"drugbank":["DB01589"],"chEBI":["8694"]},"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for insomnia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200506","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO","inchiKey":"NNRXCKZMQLFUPL-WBMZRJHASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN LACTOBIONATE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL532","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erythrocin","Erythromycin","Erythromycin lactobionate"],"synonyms":["Erythromycin lactobionate","Erythromycini lactobionas","Sterile erythromycin lactobionate"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 2 investigational indications."}
{"id":"CHEMBL1201003","canonicalSmiles":"Br.CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12","inchiKey":"UTINOWOSWSPFLJ-FSRHSHDFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELETRIPTAN HYDROBROMIDE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1510","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Relpax"],"synonyms":["Eletriptan hbr","Eletriptan hydrobromide","NSC-759258","UK-116,044-04","UK-116044-04"],"crossReferences":{"DailyMed":["eletriptan%20hydrobromide"],"chEBI":["61176"]},"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546","ENSG00000179097"],"count":3},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2002 and is indicated for migraine disorder."}
{"id":"CHEMBL1201102","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21.Cl","inchiKey":"FTNWXGFYRHWUKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLUPROMAZINE HYDROCHLORIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL570","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vesprin"],"synonyms":["MC-4703","NSC-14959","NSC-17473","Triflupromazine hcl","Triflupromazine hydrochloride"],"crossReferences":{"PubChem":["144204828","170465325","26747673","26747674","50107065","50107066","50107067","540840","541291","56422371","57288079","855673"],"chEBI":["9712"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957."}
{"id":"CHEMBL1201109","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"WBGKWQHBNHJJPZ-LECWWXJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESONIDE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desonate","Desonide","Desowen","Tridesilon","Verdeso"],"synonyms":["D-2083","D2083","Desonate","Desonide","NSC-759226"],"crossReferences":{"DailyMed":["desonide"],"PubChem":["144206156","170464832"],"Wikipedia":["Desonide"],"drugbank":["DB01260"],"chEBI":["204734"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000701","EFO_0000676","EFO_0000274","EFO_0005752"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 3 approved indications."}
{"id":"CHEMBL1201110","canonicalSmiles":"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21.Cl","inchiKey":"ZCDDBUOENGJMLV-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALACYCLOVIR HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1349","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Valacyclovir hydrochloride","Valtrex"],"synonyms":["256-U-87 HYDROCHLORIDE","256U87 HYDROCHLORIDE","BW-256","BW-256U87","NSC-759101","Valaciclovir (as hydrochloride)","Valaciclovir hydrochloride","Valacyclovir hcl","Valacyclovir hydrochloride"],"crossReferences":{"DailyMed":["valacyclovir%20hydrochloride"],"PubChem":["144205291","170465373","49681602"],"chEBI":["9919"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 4 approved and 6 investigational indications."}
{"id":"CHEMBL1201163","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"OJCZPLDERGDQRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUFENTANIL CITRATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL658","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dsuvia","Sufenta","Sufenta preservative free","Sufental","Sufentanil citrate"],"synonyms":["R 33800","R-33800","Sufentanil citrate","Sufentanil citrate cii"],"crossReferences":{"DailyMed":["sufentanil%20citrate"],"PubChem":["144206432","85273816"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for pain. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201165","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C","inchiKey":"PWZUUYSISTUNDW-VAFBSOEGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINESTROL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estrovis"],"synonyms":["NSC-759637","Quinestrol","W 3566","W-3566"],"crossReferences":{"PubChem":["11532988","144205893","170465054","29217904","56422146"],"Wikipedia":["Quinestrol"],"drugbank":["DB04575"],"chEBI":["8716"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201270","canonicalSmiles":"C1N2CN3CN1CN(C2)C3","inchiKey":"VKYKSIONXSXAKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHENAMINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uritone","Urotropin"],"synonyms":["Aminoform","E-239","E239","Hexamethylenamine","Hexamethylene tetramine","Hexamethylenetetramine","Hexamine","INS NO.239","INS-239","Methenamine","NSC-26346","NSC-403347"],"crossReferences":{"DailyMed":["methenamine%20hippurate"],"PubChem":["144207004","144208804","144210820","170465468","57260105"],"Wikipedia":["Hexamethylenetetramine"],"drugbank":["DB06799"],"chEBI":["6824"]},"childChemblIds":["CHEMBL1201104","CHEMBL3833312","CHEMBL3707448"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL1201349","canonicalSmiles":"C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21","inchiKey":"HDZAQYPYABGTCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAFLUORENIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hexafluorenium","Hexafluorenium cation","Hexafluorenium ion","Hexafluronium"],"crossReferences":{"drugbank":["DB00941"]},"childChemblIds":["CHEMBL1200933"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201776","canonicalSmiles":"CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C","inchiKey":"KWTWDQCKEHXFFR-SMDDNHRTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TAPENTADOL","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BN 200 (BASE)","BN-200","CG-5503","CG5503","CG5503 (BASE)","CG5503 IR","NSC-759619","Tapentadol"],"crossReferences":{"DailyMed":["tapentadol%20hydrochloride"],"Wikipedia":["Tapentadol"],"drugbank":["DB06204"]},"childChemblIds":["CHEMBL1201777"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000616","MONDO_0001583","HP_0012532","HP_0003418","EFO_0003843","EFO_1000783","HP_0005184","EFO_1000786","EFO_0003100","EFO_0004616","HP_0003419","EFO_1000999","HP_0001822","MONDO_0005178"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1233274","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC(=O)O","inchiKey":"YJPIDPAGJSWWBE-FNIAAEIWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233274","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56423683","855719"],"drugbank":["DB07891"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233349","canonicalSmiles":"OCC1=C[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"PJPGMULJEYSZBS-VZFHVOOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Streptol"],"crossReferences":{"Wikipedia":["Valienol"],"drugbank":["DB03092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234133","canonicalSmiles":"COc1cccc(OC)c1-c1cc2cnc(N)nc2nc1N","inchiKey":"LRPHIAJXODIASX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234133","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08145"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234797","canonicalSmiles":"NCCCNc1ccccc1[N+](=O)[O-]","inchiKey":"GVGDDEYVTBKACE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234797","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08291"]},"childChemblIds":["CHEMBL3221533"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235646","canonicalSmiles":"C=C1CS[C@H]([C@H](NC(=O)CCCC[C@@H](N)C(=O)O)C(=O)O)N=C1C(=O)O","inchiKey":"JGKXEMYIHDYWCZ-JFUSQASVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALOSPORIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cephalosporin"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1236594","canonicalSmiles":"COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O","inchiKey":"SOECUQMRSRVZQQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Coenzyme Q1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ubiquinone-1"],"crossReferences":{"drugbank":["DB08689"],"chEBI":["46234"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1238","canonicalSmiles":"O=C(O)CCCCCCCC(=O)O","inchiKey":"BDJRBEYXGGNYIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELAIC ACID","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azelex","Finacea","Skinoren"],"synonyms":["Anchoic acid","Azelaic acid","Azelate","Lepargylic acid","NSC-19493","ZK 62498","ZK-62498"],"crossReferences":{"DailyMed":["azelaic%20acid"],"PubChem":["11110663","144209187","144213328","170465358","50105776","56422409","8139926","85230873","90341560"],"Wikipedia":["Azelaic_acid"],"drugbank":["DB00548"],"chEBI":["48131"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL124162","canonicalSmiles":"CCC(=O)O[C@]1(CC)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1","inchiKey":"YCNIQYLWIPCLNY-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMPTOTHECIN-20-O-PROPIONATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Camptothecin-20-o-propionate"],"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000702","EFO_0000574"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1275802","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)CC)C(C)C","inchiKey":"KGZGFSNZWHMDGZ-KAYYGGFYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PEXIGANAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pexiganan"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1346","canonicalSmiles":"NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1","inchiKey":"HXGBXQDTNZMWGS-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARIFENACIN","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Darifenacin","Darifenacin extended release","Enablex","UK-88525"],"crossReferences":{"DailyMed":["darifenacin%20hydrobromide"],"PubChem":["50113277"],"Wikipedia":["Darifenacin"],"drugbank":["DB00496"],"chEBI":["391960"]},"childChemblIds":["CHEMBL1200935"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0006865","HP_0000020","EFO_1000781","HP_0000103"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL1349073","canonicalSmiles":"CCOC(=O)COc1ccc2c(=O)cc(-c3ccccc3)oc2c1","inchiKey":"ZVXBAHLOGZCFTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFLOXATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efloxate","NSC-758891"],"crossReferences":{"PubChem":["124894102","124894103","144206728","144206729","26729810"],"drugbank":["DB13333"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL139877","canonicalSmiles":"NC(=O)NS(=O)(=O)c1ccc(N)cc1","inchiKey":"WVAKABMNNSMCDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACARBAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Dermatological toxicity"," Hematological toxicity"," Hepatotoxicity"],"year":1988},"tradeNames":["Uromide"],"synonyms":["Euvernil","N-sulfanilylcarbamide","NSC-78438","Sulfacarbamide","Sulfaurea","Sulphaurea","Uractyl","Uramid","Urenil","Urosulfan"],"crossReferences":{"PubChem":["144205723","170466277"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1988 due to Dermatological toxicity,  Hematological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL1483","canonicalSmiles":"CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1","inchiKey":"HXHWSAZORRCQMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBENDAZOLE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Albenza","Eskazole","Valbazen","Zental","Zentel"],"synonyms":["Albendazole","Albendazolum","Andazol","NSC-220008","SK&F 62979","SK&F-62979"],"crossReferences":{"DailyMed":["albendazole"],"PubChem":["11112790","124882630","124882632","144204210","144212617","170464897","26746999","855809"],"Wikipedia":["Albendazole"],"drugbank":["DB00518"],"chEBI":["16664"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 approved and 12 investigational indications."}
{"id":"CHEMBL149603","canonicalSmiles":"N#Cc1ccc2cccc(OP(=O)(O)O)c2n1","inchiKey":"NQLPTOOPFMPCHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL149603","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02762"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1512949","canonicalSmiles":"O=C(CN1CCN(Cc2ccc3c(c2)OCO3)CC1)N1c2ccccc2Sc2ccccc21","inchiKey":"UBAJTZKNDCEGKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOVERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenoverine","Spasmopriv"],"crossReferences":{"PubChem":["144205534","170466194","29216372"],"drugbank":["DB13042"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1559","canonicalSmiles":"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O","inchiKey":"MCCACAIVAXEFAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MICONAZOLE NITRATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL91","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acorvio","Daktarin aktiv","Dermonistat","Femeron","Gyno-daktarin","M-zole 3 combination pack","M-zole 7 dual pack","Miconazole 3","Miconazole 3 combination pack","Miconazole 7","Miconazole 7 combination pack","Miconazole nitrate","Miconazole nitrate combination pack","Monistat","Monistat 1 combination pack","Monistat 3","Monistat 3 combination pack","Monistat 3 combination pack (prefilled)","Monistat 5","Monistat 7","Monistat 7 combination pack","Monistat-3 Combination Pack","Monistat-derm"],"synonyms":["Baza cream","Baza cream antifungal","Miconazole nitrate","Miconazoli nitras","NSC-169434","Priconazole","R 14,889","R-14889"],"crossReferences":{"DailyMed":["miconazole%20nitrate"],"PubChem":["26748144","562772","56422501","855623"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 2 investigational indications."}
{"id":"CHEMBL1593566","canonicalSmiles":"CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)c1cccc(Oc2ccccc2)c1","inchiKey":"OWZREIFADZCYQD-NSHGMRRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELTAMETHRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decamethrin","Deltamethrin"],"crossReferences":{"PubChem":["144208630","144213326","26757319","29216447"],"Wikipedia":["Deltamethrin"],"drugbank":["DB13600"],"chEBI":["4388"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL159776","canonicalSmiles":"CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C","inchiKey":"ZULJGOSFKWFVRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMIRACETAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pramiracetam"],"crossReferences":{"PubChem":["174006794"],"Wikipedia":["Pramiracetam"],"drugbank":["DB13247"]},"childChemblIds":["CHEMBL2106874","CHEMBL2105204"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL16073","canonicalSmiles":"CCOc1ccc(NC(C)=O)cc1","inchiKey":"CPJSUEIXXCENMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENACETIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"," Denmark"],"classes":["Nephrotoxicity"],"year":1980},"tradeNames":[],"synonyms":["Acetamide, n-(4-ethoxyphenol)-","Acetophenetidin","Acetphenetidin","Fenidina","Kalmin","NSC-7651","P-acetophenetidide","Phenacetin","Phenacetinum","Phenazetin"],"crossReferences":{"PubChem":["11112166","124882016","144203898","144209124","144213212","170465554","17389770","26747350","26752987","50086861"],"TG-GATEs":["138"],"Wikipedia":["Phenacetin"],"drugbank":["DB03783"],"chEBI":["8050"]},"childChemblIds":["CHEMBL461346"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever. It was withdrawn in United Kingdom,  United States,  Germany and  Denmark initially in 1980 due to Nephrotoxicity."}
{"id":"CHEMBL1615933","canonicalSmiles":"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O","inchiKey":"MVPAMLBUDIFYGK-BHDRXCTLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OMIGANAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omiganan"],"crossReferences":{"drugbank":["DB06610"]},"childChemblIds":["CHEMBL1793889"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1644698","canonicalSmiles":"O=[N+]([O-])[O-].[Na+]","inchiKey":"VWDWKYIASSYTQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM NITRATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chile saltpeter","Cubic niter","E-251","E251","INS NO.251","INS-251","NSC-77390","Natrum nitricum","Nitric acid sodium salt (1:1)","Soda niter","Sodium nitrate"],"crossReferences":{"PubChem":["144209793"],"Wikipedia":["Sodium_nitrate"],"chEBI":["63005"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1738","canonicalSmiles":"C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1","inchiKey":"BMKDZUISNHGIBY-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXRAZOXANE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardioxane","Zinecard"],"synonyms":["ADR-529","Dexrazoxane","ICRF-187","NSC-169780","Razoxane, (s)-","Razoxane, d-"],"crossReferences":{"DailyMed":["dexrazoxane%20hydrochloride"],"PubChem":["144205809","170464709","442425"],"Wikipedia":["Dexrazoxane"],"drugbank":["DB00380"],"chEBI":["50223"]},"childChemblIds":["CHEMBL1200778"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000637","EFO_1000292","EFO_0000220","EFO_0000318","MONDO_0007254","MONDO_0000870","EFO_0000222","EFO_0000502","EFO_1001968","EFO_0000209","EFO_0000621","EFO_1000984","EFO_0000311","EFO_0000565","MONDO_0005301","EFO_0000174","EFO_0000574","EFO_0002918","MONDO_0020743","EFO_0000691","HP_0030680","EFO_1000158"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for breast cancer and cardiomyopathy and has 22 investigational indications."}
{"id":"CHEMBL1741134","canonicalSmiles":"O=S(=O)(O)Oc1ccc(C(c2ccc(OS(=O)(=O)O)cc2)c2ccccn2)cc1","inchiKey":"UJIDKYTZIQTXPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICOSULFURIC ACID","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Picosulfate"],"crossReferences":{"DailyMed":["sodium%20picosulfate"],"drugbank":["DB09268"]},"childChemblIds":["CHEMBL1697768"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for constipation."}
{"id":"CHEMBL1743011","drugType":"Antibody","blackBoxWarning":false,"name":"ENAVATUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enavatuzumab","PDL 192","PDL-192"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743033","drugType":"Antibody","blackBoxWarning":false,"name":"ITOLIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMAB-600","EQ001","Itolizumab"],"linkedTargets":{"rows":["ENSG00000013725"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","MONDO_0004979","EFO_0004599"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1788388","canonicalSmiles":"CCCCOC(=O)CCC(=O)OCCCC","inchiKey":"YUXIBTJKHLUKBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBUTYLSUCCINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibutylsuccinate"],"crossReferences":{"PubChem":["144211831"],"drugbank":["DB13332"],"chEBI":["82263"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1823681","canonicalSmiles":"CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1","inchiKey":"NULMGOSOSZBEQL-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETILEVODOPA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etilevodopa","L-dopa ethyl ester","TV-1203"],"crossReferences":{"drugbank":["DB06535"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1887585","canonicalSmiles":"[Na+].[O-][Cl+][O-]","inchiKey":"UKLNMMHNWFDKNT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1887585","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1906899","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144213117","17389734"],"drugbank":["DB13210"],"chEBI":["78667"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL188952","canonicalSmiles":"CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1","inchiKey":"PIDSZXPFGCURGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRPROFEN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," Germany"," France"],"classes":["Gastrotoxicity"," Hepatotoxicity"],"year":1990},"tradeNames":[],"synonyms":["Pirprofen","Racemic pirprofen","Rangasil 400","Rengasil","SU 21524","SU-21524","Seflenyl"],"crossReferences":{"Wikipedia":["Pirprofen"],"drugbank":["DB13722"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and is indicated for rheumatic disease. It was withdrawn in Spain,  Germany and  France initially in 1990 due to Gastrotoxicity and  Hepatotoxicity."}
{"id":"CHEMBL191083","canonicalSmiles":"CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1","inchiKey":"RBTBFTRPCNLSDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHYLENE BLUE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DNDI1417128"],"crossReferences":{"DailyMed":["methylene%20blue"],"PubChem":["124893332","29215388","50112749"],"drugbank":["DB08167"],"chEBI":["43830"]},"childChemblIds":["CHEMBL405110","CHEMBL550495"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for urinary tract infection and has 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL207602","canonicalSmiles":"CCCCCCCCCCCCCC(=O)OC(C)C","inchiKey":"AXISYYRBXTVTFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROPYL MYRISTATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Estergel"],"synonyms":["FEMA NO. 3556","Isopropyl myristate","NSC-406280"],"crossReferences":{"PubChem":["144205633","144209263","144213488","170465683","26757488"],"drugbank":["DB13966"],"chEBI":["90027"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL20883","canonicalSmiles":"O=c1[nH]c(=O)n(C2CCCO2)cc1F","inchiKey":"WFWLQNSHRPWKFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGAFUR","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Citofur","Uftoral"],"synonyms":["Atillon","BMS-200604","Coparogin","Exonal","FT-207","Fental","Franrose","Ftorafur","Fulaid","Fulfeel","Furafluor","Furofutran","Futraful","J356.722B","Lamar","Lifril","MJF-12264","NSC-148958","Neberk","Nitobanil","Sinoflurol","Sunfural","Tefsiel c","Tegafur","Tegafur-uracil","Youfuding"],"crossReferences":{"PubChem":["144205202","144212129","170465809","26754499","29215356","56422217","8139878"],"Wikipedia":["Tegafur"],"drugbank":["DB09256"],"chEBI":["32188"]},"linkedTargets":{"rows":["ENSG00000176890"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0003891","EFO_0000365","EFO_1001901","MONDO_0007254","EFO_1000657","EFO_0004252","MONDO_0021063","EFO_0000228","MONDO_0044937","EFO_1001951","MONDO_0001187","MONDO_0001056","EFO_1001480","EFO_0000178","EFO_1000044","EFO_1000218","EFO_0003860","MONDO_0002974","EFO_0009812","EFO_0000182","EFO_1000045","EFO_0002618","EFO_0003897","EFO_0000616","EFO_0006859","EFO_0005922","EFO_1001956","EFO_0002916","EFO_0000503","EFO_0005842","MONDO_0007576","EFO_0003060","EFO_0005221","EFO_0000311","MONDO_0002120","EFO_0002517","EFO_0004142","EFO_0000199","EFO_0000702","MONDO_0003219","MONDO_0021355","EFO_0000181"],"count":44},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and cancer and has 37 investigational indications."}
{"id":"CHEMBL2103849","canonicalSmiles":"CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1","inchiKey":"IYFNEFQTYQPVOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UDENAFIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA-8159","Udenafil","Zydena"],"crossReferences":{"drugbank":["DB06267"]},"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0001361","EFO_0004718","EFO_0004234","EFO_0001421","MONDO_0004975","EFO_1000657","EFO_1001207","MONDO_0008315","EFO_1001145","EFO_1000899"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2103995","canonicalSmiles":"C=CCC1CN(C)CCC1(OC(=O)CC)c1ccccc1","inchiKey":"KGYFOSCXVAXULR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLYLPRODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACSCN-9602","Allylprodine","Alperidine","DEA NO. 9602","IDS-NA-007","NIH-7440","Ro 2-7113"],"crossReferences":{"drugbank":["DB01542"]},"childChemblIds":["CHEMBL3246685"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104217","canonicalSmiles":"O=C([O-])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].[Ca+2]","inchiKey":"UGZVNIRNPPEDHM-SBBOJQDXSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM SACCHARATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium d-glucarate","Calcium d-glucarate (1:1)","Calcium d-saccharate","Calcium glucarate","Calcium saccharate","Calcium saccharate anhydrous","Calcium saccharate tetrahydrate","D-glucaric acid calcium salt","NSC-122011","Saccharated lime"],"crossReferences":{"drugbank":["DB13962"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104607","canonicalSmiles":"CCN(CC)C(=O)c1cccnc1","inchiKey":"NCYVXEGFNDZQCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIKETHAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Multiple unspecified markets"],"classes":["Neurotoxicity"],"year":1988},"tradeNames":["Coramine","Nikethyl"],"synonyms":["Carditonic","NSC-130820","Nicethamide","Nikethamide"],"crossReferences":{"PubChem":["225144265"],"drugbank":["DB13655"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for respiratory system disease. It was withdrawn in Multiple unspecified markets  in 1988 due to Neurotoxicity."}
{"id":"CHEMBL2104954","canonicalSmiles":"COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1N1CCC(N2CCCC2)CC1","inchiKey":"CVAKNHIXTWLGJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALAMAPIMOD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balamapimod","MKI-833"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105684","canonicalSmiles":"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21.O=S(=O)(O)O","inchiKey":"GRKFGZYYYYISDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELUMETINIB SULFATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1614701","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Koselugo"],"synonyms":["AZD-6244 HYD-SULFATE","AZD-6244 HYDROGEN SULFATE","AZD6244 HYD-SULFATE","AZD6244 HYDROGEN SULFATE","Azd-6244 hydrogen sulphate","Azd6244 hydrogen sulphate","Selumetinib sulfate","Selumetinib sulphate"],"crossReferences":{"DailyMed":["selumetinib%20sulfate"]},"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000389","EFO_0008514","Orphanet_636","EFO_0000272","MONDO_0021637","EFO_0002617"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for neurofibromatosis type 1 and neurofibromatosis and has 4 investigational indications."}
{"id":"CHEMBL2106011","canonicalSmiles":"CC(=O)OCC(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C","inchiKey":"ARPLCFGLEYFDCN-CDACMRRYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOCORTOLONE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clocortolone","Clocortolone 21-acetate","Clocortolone acetate","SH 818","SH-818"],"crossReferences":{"drugbank":["DB14652"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106419","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1.Cl","inchiKey":"WMFYOYKPJLRMJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LERCANIDIPINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL250270","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardiovasc","Carmen","Corifeo","Lercadip","Lercan","Lercapin","Lercaton","Lerkamen","Lerzam","Renovia","Vasodip","Zandip","Zanicor","Zanidip"],"synonyms":["Lercanidipine hcl","Lercanidipine hydrochloride","REC-15/2375"],"crossReferences":{"PubChem":["144206046","170465587"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2106526","canonicalSmiles":"CCN(C)C(C)C=C(c1cccs1)c1cccs1","inchiKey":"MORSAEFGQPDBKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLMETHYLTHIAMBUTENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acscn-9623","Emethibutin","Ethylmethylthiambutene","IDS-NE-004","Nih-5145"],"crossReferences":{"drugbank":["DB01468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107261","canonicalSmiles":"Cc1ccc(C(CCN(C)C)c2ccccc2)cc1","inchiKey":"CINROOONPHQHPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLPROPAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tolpropamine"],"crossReferences":{"drugbank":["DB13305"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107834","canonicalSmiles":"COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N","inchiKey":"WXXSNCNJFUAIDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RIOCIGUAT","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adempas","Bay 63-2521"],"synonyms":["BAY 63-2521","BAY-63-2521","Riociguat"],"crossReferences":{"DailyMed":["riociguat"],"drugbank":["DB08931"],"chEBI":["76018"]},"linkedTargets":{"rows":["ENSG00000164116","ENSG00000061918","ENSG00000123201","ENSG00000152402"],"count":4},"linkedDiseases":{"rows":["Orphanet_797","MONDO_0005149","Orphanet_275766","EFO_0001361","Orphanet_232","Orphanet_422","EFO_0001645","Orphanet_586","MONDO_0043839","EFO_1001145","EFO_0000537","EFO_0000764","EFO_1001993","EFO_0000717"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 4 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108556","drugType":"Protein","blackBoxWarning":false,"name":"PEXIGANAN ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cytolex"],"synonyms":["Locilex","MSI-78","Pexiganan acetate"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108705","drugType":"Unknown","blackBoxWarning":false,"name":"ASTUPROTIMUT-R","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Astuprotimut r","Astuprotimut-r","GSK-1572932A","GSK-249553","GSK1572932A","Hp3tut3x8x","MAGE-A3","Mage a3 protein","Mage-a3 asci","SB-249553","Zastumotide"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109073","drugType":"Unknown","blackBoxWarning":false,"name":"HORSE CHESTNUT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aescorin","Aesculi semen","Aesculus hippocastanum","Aesculus hippocastanum dry extract","Aesculus hippocastanum extract","Aesculus hippocastanum fruit","Aesculus hippocastanum l. seed","Aesculus hippocastanum nut","Aesculus hippocastanum seed","Aesculus hippocastanum seed dry extract","Aesculus hippocastanum seed extract","Aesculus hippocastanum whole","Aescusan","Buckeye seed","Common horse chestnut nut","Essaven","European horse chestnut nut","Hippocastani semen","Horse chestnut","Horse chestnut dried extract","Horse chestnut nut","Horse chestnut seed","Horse chestnut whole","Horse-chestnut","Horse-chestnut seed","Suo luo zi","Venalot","Venoplant","Venopyronum","Venostasin"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109307","drugType":"Antibody","blackBoxWarning":false,"name":"LMB-7","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LMB-7","Lmb-7"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109308","drugType":"Antibody","blackBoxWarning":false,"name":"ONCOLYSIN B","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONCOLYSIN B"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109420","drugType":"Antibody","blackBoxWarning":false,"name":"CH14.18","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CH14.18","Dinutuximab","Dinutuximab beta"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2111176","canonicalSmiles":"CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1","inchiKey":"UPPMZCXMQRVMME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALETHAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valethamate","Valethamate cation","Valethamate ion"],"crossReferences":{"drugbank":["DB13497"]},"childChemblIds":["CHEMBL2107687"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL216543","canonicalSmiles":"O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N/O","inchiKey":"HBDSHCUSXQATPO-BGBJRWHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL216543","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124880404","124880405","162108255","17405181","26752251","26752252","50104963","50104964","85231086","90340596"],"drugbank":["DB02052"],"chEBI":["43645"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2251240","canonicalSmiles":"Br.CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.O.O.O","inchiKey":"LACQPOBCQQPVIT-SEYKEWMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCOPOLAMINE HYDROBROMIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL569713","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isopto hyoscine","Joy-rides","Kwells","Kwells kids","Scopoderm","Scopoderm tts","Transcop","Transderm-scop"],"synonyms":["Hyoscine","Hyoscine hbr","Hyoscine hydrobromide","Hyoscine hydrobromide trihydrate","NSC-61806","NSC-757314","Scopolamine hbr","Scopolamine hbr, trihydrate","Scopolamine hydrobromide","Scopolamine hydrobromide hydrate","Scopolamine hydrobromide trihydrate","Scopolaminum hydrobromidum"],"crossReferences":{"PubChem":["144204730","144208065"],"chEBI":["61272"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL228133","canonicalSmiles":"Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1","inchiKey":"HPWBHQIUIBFTQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL228133","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23393","canonicalSmiles":"CCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]","inchiKey":"DBMJMQXJHONAFJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM LAURYL SULFATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E487","NSC-402488","Sodium dodecyl sulfate","Sodium laurilsulfate","Sodium lauryl sulfate","Sodium lauryl sulfate, synthetic","Texapon k 12 p"],"crossReferences":{"DrugCentral":["4144"],"PubChem":["144204610","144208812","144210469","170465474","17388729","17388731","26752879"],"Wikipedia":["Sodium_dodecyl_sulfate"],"drugbank":["DB00815"],"chEBI":["8984"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2364618","canonicalSmiles":"CC(C)(O)c1ccccc1-c1ccc2[nH]c(/C=C/c3ccc(C(F)(F)F)cc3)nc2c1","inchiKey":"ORDHXXHTBUZRCN-NTEUORMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAVATREP","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-39439335","Mavatrep"],"crossReferences":{"drugbank":["DB12875"]},"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["EFO_0004616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL248594","canonicalSmiles":"CCCCC1OC(=O)c2ccccc21","inchiKey":"HJXMNVQARNZTEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAC-3-N-BUTYLPHTHALIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Butylphthalide","Rac-3-n-butylphthalide"],"crossReferences":{"drugbank":["DB12749"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL252557","canonicalSmiles":"O=C(O)CO","inchiKey":"AEMRFAOFKBGASW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOLIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Hydroxyacetic Acid","Glycolate","Glycolic acid","Hydroxyacetic acid","NSC-166"],"crossReferences":{"PubChem":["144211615","29216299"],"Wikipedia":["Glycolic_acid"],"drugbank":["DB03085"],"chEBI":["17497"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL290916","canonicalSmiles":"CC1=NN(c2ccccc2)C(=O)C1","inchiKey":"QELUYTUMUWHWMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDARAVONE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Radicava","Radicut"],"synonyms":["Antipyrine related compound a","C.i. developer 1","Colorex pmp","Developer z","Edaravone","Jarocol pmp","MCI-186","NSC-12","NSC-26139","NSC-2629","Norphenazone","Phenyl methyl pyrazolone","Radicut"],"crossReferences":{"DailyMed":["edaravone"],"PubChem":["11113339","124883490","144205630","144208945","144213136","170465935","17389763","26746991","26751506","26757432","56422481","855774"],"Wikipedia":["Edaravone"],"drugbank":["DB12243"],"chEBI":["31530"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for amyotrophic lateral sclerosis and has 6 investigational indications."}
{"id":"CHEMBL299001","canonicalSmiles":"Cc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1","inchiKey":"SWGDXLAZBZDUBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL299001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08528"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL312040","canonicalSmiles":"CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1","inchiKey":"PXDBZSCGSQSKST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETONITAZENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acscn-9624","Arc 1g2","BA-20684","Ciba 20-684ba","Etobedolum","Etonitazene","Etonitazine","IDS-NE-006","NIH 7607","NIH-7607"],"crossReferences":{"PubChem":["144206383"],"Wikipedia":["Etonitazene"],"drugbank":["DB01462"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184685","canonicalSmiles":"CCCCC(CC)COC(=O)c1ccccc1","inchiKey":"UADWUILHKRXHMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184685","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211793"],"drugbank":["DB11291"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184791","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"QTENRWWVYAAPBI-YCRXJPFRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"STREPTOMYCIN SULFATE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL372795","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Agri-Strep","Streptomycin sulfate","Streptorex","Vetstrep"],"synonyms":["Agrimycin 17","Agrimycin sulfate","Ambistryn s","NSC-757316","Streptomycin (as sulfate)","Streptomycin sesquisulfate","Streptomycin sulfate","Streptomycin sulphate","Streptomycini sulfas","Vetstrep"],"crossReferences":{"PubChem":["144205136"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and has 7 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3305985","canonicalSmiles":"C=CC[N@@+]12CC[C@@]34c5ccccc5N5/C=C6/[C@H]7C[C@H]8[C@@]9(CC[N@@+]8(CC=C)C/C7=C/CO)c7ccccc7N(/C=C(/[C@@H](C[C@@H]31)/C(=C\\CO)C2)[C@H]54)[C@@H]69","inchiKey":"MUQUYTSLDVKIOF-CHJKCJHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCURONIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alcuronium","Alcuronium cation","Alcuronium ion","Diallylnortoxiferine","N,n'-diallylnortoxiferinium"],"crossReferences":{"drugbank":["DB13648"],"chEBI":["55313"]},"childChemblIds":["CHEMBL3188339"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3306918","canonicalSmiles":"CC(C)n1c(=O)c(C(=O)NCCCN2CCCCC2)c(O)c2ccsc21","inchiKey":"SCHKZZSVELPJKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRX-03140","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prx-03140"],"crossReferences":{"drugbank":["DB05596"]},"childChemblIds":["CHEMBL3291085"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3318007","canonicalSmiles":"O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F","inchiKey":"JGPXDNKSIXAZEQ-SBBZOCNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMODIVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ - 63623872 - ZCD","JNJ-63623872","JNJ-63623872-ZCD","JNJ-872","JNJ63623872","JNJ872","Pimodivir","VX -787","VX-787","Vx-787 anhydrous base"],"crossReferences":{"drugbank":["DB14974"]},"childChemblIds":["CHEMBL3989964"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3334567","canonicalSmiles":"C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21","inchiKey":"XYDNMOZJKOGZLS-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAVOLITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-6094","AZD6094","Azd-6094","HMPL-504","Savolitinib","Volitinib"],"crossReferences":{"drugbank":["DB12048"]},"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000503","EFO_0000681","EFO_1000657","EFO_0000313","EFO_0003060","MONDO_0008315","EFO_1001951","EFO_0000311","EFO_0000640","EFO_0003863","MONDO_0001056","EFO_1000336","EFO_1001949"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL3544935","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-418","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["XL418","Xl-418"],"linkedTargets":{"rows":["ENSG00000175634","ENSG00000105221","ENSG00000117020","ENSG00000108443","ENSG00000142208"],"count":5},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545006","drugType":"Small molecule","blackBoxWarning":false,"name":"PWT-33587","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pwt-33587"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545061","canonicalSmiles":"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C","inchiKey":"BROGCIMRGWLMOO-SJPGHYFNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FEXAPOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fexapotide","NX-1207","NYM-4805","NYM4805"],"childChemblIds":["CHEMBL3707309"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545280","canonicalSmiles":"Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N","inchiKey":"JCYNMRJCUYVDBC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFATUTAZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efatutazone","Inolitazone"],"crossReferences":{"drugbank":["DB11894"]},"childChemblIds":["CHEMBL3545279"],"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000365","MONDO_0002108","EFO_0001378","EFO_0003060","EFO_0000569","EFO_0000311","EFO_1001951"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545318","drugType":"Cell","blackBoxWarning":false,"name":"REXLEMESTROCEL-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Neofuse","Revascor"],"synonyms":["Neofuse","Rexlemestrocel-l"],"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545321","drugType":"Small molecule","blackBoxWarning":false,"name":"NMS-1116354","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nms-1116354"],"linkedTargets":{"rows":["ENSG00000097046"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545348","drugType":"Protein","blackBoxWarning":false,"name":"BKT140","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4F-BENZOYL-TN-14003","BKT-140","BKT140","BL-8040","Bkt140","Bl 8040","Motixafortide","T140","TF 14016","TF-14016"],"linkedTargets":{"rows":["ENSG00000121966"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0000873","EFO_1000044","EFO_0000339","EFO_0002916","EFO_0000220","EFO_0000503","EFO_0000222","MONDO_0003219","EFO_0001378","EFO_0000183","HP_0001915"],"count":12},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3545393","drugType":"Small molecule","blackBoxWarning":false,"name":"XL550","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-3150","Esaxerenone","XL-550","Xl550"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["MONDO_0001134","EFO_0000401","MONDO_0001422","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL358040","canonicalSmiles":"NCC(O)c1cccc(O)c1","inchiKey":"LRCXRAABFLIVAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORFENEFRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norfenefrine","Norfenefrine hydrochloride","Norphenylephrine","WV 569 [AS HYDROCHLORIDE]"],"crossReferences":{"PubChem":["50112807"],"Wikipedia":["Norfenefrine"],"drugbank":["DB13378"]},"childChemblIds":["CHEMBL446333"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3581647","canonicalSmiles":"Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2","inchiKey":"GNMUEVRJHCWKTO-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIRABRESIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Birabresib","MK-8628","OTX-015","OTX-015 ANHYDROUS","OTX015","OTX015 ANHYDROUS","Y-803 anhydrous"],"crossReferences":{"drugbank":["DB15189"]},"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0005783","MONDO_0019457","EFO_0002517","EFO_0000403","MONDO_0007254","EFO_0000222","EFO_0000519","EFO_0003060","MONDO_0008315"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL359965","canonicalSmiles":"C=CCS[S+]([O-])CC=C","inchiKey":"JDLKFOPOAOFWQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allicin","Diallyl Thiosulfinate"],"crossReferences":{"Wikipedia":["Allicin"],"drugbank":["DB11780"],"chEBI":["28411"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3600873","canonicalSmiles":"O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1","inchiKey":"LCVIRAZGMYMNNT-VVONHTQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3600873","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12556"]},"childChemblIds":["CHEMBL3951333"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3608680","canonicalSmiles":"Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1","inchiKey":"PPSNFPASKFYPMN-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEZOLINETANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-2693","A2693","AS-3472693-00","AS3472693-00","ES-256364","ESN-364","ESN364","Esn364","Fezolinetant"],"crossReferences":{"drugbank":["DB15669"]},"linkedTargets":{"rows":["ENSG00000169836"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001421","HP_0031217"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3742465","canonicalSmiles":"CC(C)[C@]12O[C@H]1[C@@H]1O[C@@]13[C@@]1(C)CCC4=C(COC4=O)[C@@H]1C[C@@H]1O[C@@]13[C@@H]2OCOP(=O)(O)O","inchiKey":"QROUIGQWVUTWFM-RWBWCDHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINNELIDE FREE SALT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3740500"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL376044","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC2=NC(=O)/C(=C/c3ccc(C)o3)S2)cc1","inchiKey":"MXAPQGDBWFYKKX-ZROIWOOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376044","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08481"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833369","drugType":"Unknown","blackBoxWarning":false,"name":"FISH OIL","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["B1782","Fish oil"],"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2016 and has 1 investigational indication."}
{"id":"CHEMBL395308","canonicalSmiles":"O/N=C/c1ccc(-c2ccc(O)cc2)c2ccccc12","inchiKey":"VYQQTWUZKPWPRL-WOJGMQOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL395308","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07150"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL39736","canonicalSmiles":"CCCC/N=C(/N)N=C(N)N","inchiKey":"XSEUMFJMFFMCIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFORMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Metabolism toxicity"],"year":1978},"tradeNames":[],"synonyms":["Buformin","Buformin hydrochloride","DBV","W 37"],"crossReferences":{"PubChem":["144205717","170465982","26757952"],"Wikipedia":["Buformin"],"drugbank":["DB04830"],"chEBI":["3209"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for diabetes mellitus. It was withdrawn in Germany  in 1978 due to Metabolism toxicity."}
{"id":"CHEMBL3989516","canonicalSmiles":"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)([O-])[O-])C(=O)C(C)(C)O4)n2)cc(OC)c1OC.O.O.O.O.O.O.[Na+].[Na+]","inchiKey":"ZQGJCHHKJNSPMS-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSTAMATINIB DISODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103830","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tavalisse"],"synonyms":["Fostamatinib disodium","Fostamatinib disodium salt hexahydrate","R-788 SODIUM","R-788 SODIUM HYDRATE","R-935788 SODIUM","R-935788 SODIUM HYDRATE","R788 SODIUM","R788 SODIUM HYDRATE","R935788 SODIUM","R935788 SODIUM HYDRATE"],"crossReferences":{"DailyMed":["fostamatinib%20disodium"]},"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["EFO_0007160","EFO_0000685","EFO_0002690","EFO_0000574","EFO_1001264","EFO_0004194","HP_0001873"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for thrombocytopenia and autoimmune thrombocytopenic purpura and has 5 investigational indications."}
{"id":"CHEMBL3989865","canonicalSmiles":"C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@@H](OC(=O)CCCCCCCCCCCNC(=O)C[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC","inchiKey":"UPYNTAIBQVNPIH-ODMLWHIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIPSAGARGIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G-202","Mipsagargin"],"crossReferences":{"drugbank":["DB11813"]},"linkedTargets":{"rows":["ENSG00000074370","ENSG00000174437","ENSG00000196296"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000349","EFO_0000182","EFO_0000673","EFO_0000519","MONDO_0008315"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3989939","canonicalSmiles":"O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1.O=S(=O)(O)O","inchiKey":"PXHANKVTFWSDSG-QLOBERJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAROTRECTINIB SULFATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3889654","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitrakvi"],"synonyms":["ARRY-470 SULFATE","LOXO-101 sulfate","Larotrectinib sulfate"],"crossReferences":{"DailyMed":["larotrectinib%20sulfate"]},"linkedTargets":{"rows":["ENSG00000140538","ENSG00000148053","ENSG00000198400"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000311","EFO_0009708"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved indications."}
{"id":"CHEMBL3990016","drugType":"Antibody","blackBoxWarning":false,"name":"OLECLUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-9447","MEDI9447","Oleclumab"],"linkedTargets":{"rows":["ENSG00000135318"],"count":1},"linkedDiseases":{"rows":["EFO_0000311","EFO_0000616","EFO_0003869","EFO_1000044","MONDO_0007254","EFO_0003060","MONDO_0008315","MONDO_0021115","MONDO_0001187"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3990023","drugType":"Protein","blackBoxWarning":false,"name":"TOZULERISTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BLZ-100","Tozuleristide"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL408967","canonicalSmiles":"COc1cc2c(cc1OS(N)(=O)=O)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@H]2CC#N","inchiKey":"NTSPHKOMJMBWOU-NNKXXINSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL408967","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07596"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4217292","canonicalSmiles":"N#Cc1ccc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)nc1","inchiKey":"LSYANGLAZUZYFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACT-709478","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-709478","Act-709478"],"childChemblIds":["CHEMBL4204434"],"linkedTargets":{"rows":["ENSG00000100346","ENSG00000006283","ENSG00000196557"],"count":3},"linkedDiseases":{"rows":["MONDO_0015643"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297298","canonicalSmiles":"CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC.Cl","inchiKey":"CKMGYWHSTADSIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KW-2478","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4300557","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kw 2478","Kw-2478"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297371","canonicalSmiles":"[2H]C([2H])([2H])[C@H](O)C([2H])([2H])CCCn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"NSMXQKNUPPXBRG-WHPHVCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PCS-499","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4300766","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CTP-499","Ctp-499","Deuterated s-lisofylline","PCS-499","PCS499","Pcs-499","Pcs499"],"crossReferences":{"drugbank":["DB15122"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297474","canonicalSmiles":"C[C@@H](OP(=O)(N1CC1)N1CC1)c1ccc([N+](=O)[O-])c(Oc2cccc(C(=O)N(C)C)c2)c1","inchiKey":"NWGZZGNICQFUHV-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBI-3424","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OBI-3424","Obi-3424","TH-3424"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297723","drugType":"Antibody","blackBoxWarning":false,"name":"CEMIPLIMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Libtayo"],"synonyms":["Cemiplimab","Cemiplimab-rwlc","REGN-2810","REGN2810","Regn2810"],"crossReferences":{"DailyMed":["cemiplimab-rwlc"]},"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["MONDO_0015686","EFO_0000756","EFO_0000681","MONDO_0007254","MONDO_0020657","MONDO_0002158","EFO_1000044","EFO_0003968","MONDO_0002974","EFO_0009709","MONDO_0002898","MONDO_0008903","EFO_0000183","EFO_0004193","EFO_0000707","EFO_0000616","EFO_0002618","MONDO_0008170","EFO_0004197","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1000026","EFO_1001471","MONDO_0002529","EFO_0005537","EFO_0000764","EFO_0000574","EFO_0001378","EFO_1001927","MONDO_0024880","EFO_0000519","EFO_0000181","MONDO_0044926"],"count":34},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 6 approved and 21 investigational indications."}
{"id":"CHEMBL4297767","drugType":"Unknown","blackBoxWarning":false,"name":"HYLAN G-F 20","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hyaluronic acid crosslinked","Hyaluronic acid, crosslinked","Hylan g-f 20","Synvisc"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297793","drugType":"Protein","blackBoxWarning":false,"name":"NANGIBOTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LR-12","Motrem","Nangibotide"],"linkedTargets":{"rows":["ENSG00000124731"],"count":1},"linkedDiseases":{"rows":["EFO_0006834","MONDO_0100096"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297808","drugType":"Unknown","blackBoxWarning":false,"name":"PF-06823859","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06823859","PF06823859","Pf-06823859"],"linkedTargets":{"rows":["ENSG00000171855"],"count":1},"linkedDiseases":{"rows":["EFO_0000398"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297854","drugType":"Unknown","blackBoxWarning":false,"name":"CABIOTRAXETAN LUTETIUM LU-177","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(177lu)dota-biotin","177LU-ST2210","177lu-st2210","Cabiotraxetan lutetium lu-177","ST-2210 LU-177"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298129","drugType":"Unknown","blackBoxWarning":false,"name":"HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Human coagulation factor viii/von willebrand factor complex","Wilate"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL430266","canonicalSmiles":"COC[C@@H]([C@H](O)[C@H](O)C(=O)NCC[C@H](C)c1nc(/C=C/C[C@@H]2O[C@]3(C[C@@H](O)[C@@H]2C)O[C@H]([C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C(C)/C(C)=C/C=C/C(C)=C\\C#N)OC)[C@H](OP(=O)(O)O)C3(C)C)co1)N(C)C","inchiKey":"FKAWLXNLHHIHLA-YCBIHMBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALYCULIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26755755"],"drugbank":["DB02860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL444","canonicalSmiles":"CCC1(CC)C(=O)NC(=O)NC1=O","inchiKey":"FTOAOBMCPZCFFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Barbital","Barbitone","Diemal","Diethylbarbituric acid","NSC-31352"],"crossReferences":{"PubChem":["170465829","29215357"],"Wikipedia":["Barbital"],"drugbank":["DB01483"],"chEBI":["31252"]},"childChemblIds":["CHEMBL2105904"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL450656","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@@H]1C(=O)N1C[C@@H](O)C[C@@H]1C(=O)NCC(=O)N[C@H](C)C(=O)NCC(N)=O","inchiKey":"GFJRASPBQLDRRY-TWTQBQJDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ROTIGAPTIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GAP (WYETH)","Rotigaptide","ZP-123","ZP-123 (ZEALAND)"],"crossReferences":{"Wikipedia":["Rotigaptide"],"drugbank":["DB13067"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594427","canonicalSmiles":"CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CNC(C)=O)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCCCCCCCCCCCC","inchiKey":"VITDDUXZOHEQMU-BYSUZVQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABX-196","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-196","ABX196","Abx-196","Abx196","PBS 96"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594567","drugType":"Unknown","blackBoxWarning":false,"name":"KHK-4083","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KHK-4083","KHK4083","Khk-4083","Khk4083","Rocatinlimab"],"linkedTargets":{"rows":["ENSG00000186827"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000274"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650301","canonicalSmiles":"CC(C)[C@H](N)C(=O)NCCCS(=O)(=O)O","inchiKey":"NRZRFNYKMSAZBI-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALZ-801","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALZ-801","Alz-801","BLU-8499","BLU8499","NRM-8499","NRM8499"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650408","drugType":"Unknown","blackBoxWarning":false,"name":"MRX-2843","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MRX-2843","Mrx-2843","UNC-2371A"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL495","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O","inchiKey":"GMVPRGQOIOIIMI-DWKJAMRDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALPROSTADIL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alprostadil","Caverject","Caverject impulse","Edex","Prostin","Prostin vr","Prostin vr pediatric","Viridal 10","Viridal 20","Viridal 5","Viridal duo","Vitaros"],"synonyms":["Alprostadil","NSC-165559","ONO-1608","Pge1","Prostaglandin e1","U-10,136","U-10136"],"crossReferences":{"DailyMed":["alprostadil"],"PubChem":["144204033","49681576"],"Wikipedia":["Prostaglandin_E1"],"drugbank":["DB00770"],"chEBI":["15544"]},"linkedTargets":{"rows":["ENSG00000160951","ENSG00000125384"],"count":2},"linkedDiseases":{"rows":["MONDO_0002492","MONDO_0100130","EFO_0003875","EFO_1000809","EFO_0004234","HP_0001643","EFO_0000401","EFO_0009085","EFO_0000556","EFO_0001645","EFO_0000319","MONDO_0008315","EFO_0002950","EFO_0009606","EFO_0004714","MONDO_0100096","EFO_1000820","MONDO_0000831","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0000612","EFO_0004265"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL495758","canonicalSmiles":"c1ccc2[nH]c(-c3cc[nH]n3)nc2c1","inchiKey":"IYTGPPNUOLLGBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL495758","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08065"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL502","canonicalSmiles":"COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2","inchiKey":"ADEBPBSSDYVVLD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DONEPEZIL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aricept","D-797","Donaz","Donepezil","E-2020"],"crossReferences":{"DailyMed":["donepezil%20hydrochloride"],"PubChem":["50112790"],"Wikipedia":["Donepezil"],"drugbank":["DB00843"],"chEBI":["53289"]},"childChemblIds":["CHEMBL2171854","CHEMBL1678","CHEMBL2337271"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","EFO_0009386","EFO_0004718","HP_0000726","EFO_1001454","EFO_0003768","EFO_0009267","Orphanet_778","EFO_0004698","MONDO_0005277","HP_0100543","EFO_0000289","MONDO_0002050","EFO_0003931","MONDO_0005180","EFO_0000712","EFO_0003884","HP_0003419","EFO_0001064","MONDO_0007079","EFO_0005230","EFO_1000158","EFO_0005762","EFO_0003756","HP_0002140","MONDO_0001020","EFO_0003758","Orphanet_240071","EFO_0003929","EFO_0000701","EFO_0006792","HP_0002381","Orphanet_908","EFO_0000311","EFO_0000546","EFO_0001072","MONDO_0005301","MONDO_0004975","MONDO_0005148","EFO_0003918","EFO_0005411","MONDO_0002025"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for dementia and alzheimer disease and has 31 investigational indications."}
{"id":"CHEMBL503481","canonicalSmiles":"CCCCCCCCCCCCCCSCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CSCCCCCCCCCCCCCC","inchiKey":"ZZWQHNRGJQENEP-KXQOOQHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHATIDYLCHOLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphatidylcholine","Phospholipids egg"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL52125","canonicalSmiles":"CCN(CC)CCCN1c2ccccc2Sc2ccc(Cl)cc21","inchiKey":"DBOUGBAQLIXZLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPROETHAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorproethazine"],"crossReferences":{"drugbank":["DB13382"]},"childChemblIds":["CHEMBL2105938"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL525028","canonicalSmiles":"CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O","inchiKey":"VBUWHHLIZKOSMS-KDPLEQQTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VASOACTIVE INTESTINAL PEPTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vasoactive intestinal peptide","Vip"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL54349","canonicalSmiles":"CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12","inchiKey":"JRTIDHTUMYMPRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPIDEM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1993},"tradeNames":[],"synonyms":["Alpidem","SL 80.0342-00","SL-80.0342-00"],"crossReferences":{"PubChem":["144207142","170466634"],"Wikipedia":["Alpidem"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1993 due to Hepatotoxicity."}
{"id":"CHEMBL549340","canonicalSmiles":"Nc1ncc(/N=N/c2ccccc2)c(-c2ccc(Cl)cc2Cl)n1","inchiKey":"UNJMNJFPEVJCQK-GHVJWSGMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549340","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08787"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL552128","canonicalSmiles":"C=C1CC[C@H]2[C@@H](/C=C(\\C)C(=O)[C@@]3(OC(C)=O)C[C@H](C)[C@H](OC(=O)c4ccccc4)[C@@H]3[C@H]1OC(C)=O)C2(C)C","inchiKey":"JPYYWXPAHJBKJX-VWSFRBHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL552128","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11260"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL564","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccccc21","inchiKey":"ZGUGWUXLJSTTMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROMAZINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Combelen","NSC-31447","Promazine"],"crossReferences":{"PubChem":["11111651","11111652","124881158","50100325","50104276","90341344"],"Wikipedia":["Promazine"],"drugbank":["DB00420"],"chEBI":["8459"]},"childChemblIds":["CHEMBL1200469"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0005407"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956 and is indicated for psychosis."}
{"id":"CHEMBL58323","canonicalSmiles":"COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1","inchiKey":"VPPJLAIAVCUEMN-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERLOSAMIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lacosamide","Vimpat"],"synonyms":["(r)-lacosamide 1","ADD 243037","ADD-243037","Erlosamide","Lacosamide","Lacosamide cv","SPM 927","SPM-927"],"crossReferences":{"DailyMed":["lacosamide"],"PubChem":["170466190"],"Wikipedia":["Lacosamide"],"drugbank":["DB06218"]},"childChemblIds":["CHEMBL1213900"],"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0005762","EFO_0008526","EFO_0003086","MONDO_0005090","EFO_0005687","MONDO_0041052","HP_0000726","HP_0001250","EFO_1000783","MONDO_0005277","EFO_0000474","MONDO_0002050","EFO_0004263","EFO_0000326","EFO_0004149","MONDO_0007079","MONDO_0004976","EFO_0003833","EFO_0005230","MONDO_0005178"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for epilepsy and seizure and has 18 investigational indications."}
{"id":"CHEMBL594722","canonicalSmiles":"NN1C(=O)N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O","inchiKey":"KLJXQBRQPPSXPZ-WWHASAIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL594722","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01843"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL601","canonicalSmiles":"NCC(=O)CCC(=O)O","inchiKey":"ZGXJTSGNIOSYLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOLEVULINIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".delta.-aminolevulinic acid","Aminolevulinic acid","Levulan"],"crossReferences":{"DailyMed":["aminolevulinic%20acid%20hydrochloride"],"PubChem":["56322917"],"Wikipedia":["Aminolevulinic_acid"],"drugbank":["DB00855"],"chEBI":["17549"]},"childChemblIds":["CHEMBL18851","CHEMBL3350765","CHEMBL1200582","CHEMBL3350389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 32 investigational indications."}
{"id":"CHEMBL61946","canonicalSmiles":"CCN(CC)CCOC(=O)C1(c2ccccc2)CCCC1","inchiKey":"OFAIGZWCDGNZGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARAMIPHEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caramiphen"],"crossReferences":{"drugbank":["DB11504"]},"childChemblIds":["CHEMBL1598472","CHEMBL2355683"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL64677","canonicalSmiles":"O=C1C(O)N=C(c2ccccc2F)c2cc(Cl)ccc2N1CCO","inchiKey":"VOJLELRQLPENHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXEFAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Doxefazepam","Sas-643"],"crossReferences":{"Wikipedia":["Doxefazepam"],"drugbank":["DB13837"],"chEBI":["82460"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL66424","canonicalSmiles":"C=CCN(C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)nn(C)c2c1","inchiKey":"FNZKIJOTNKEJBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL66424","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03888"]},"childChemblIds":["CHEMBL115497"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7303","canonicalSmiles":"COC(=O)C1=CCCN(C)C1","inchiKey":"HJJPJSXJAXAIPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARECOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-56321"],"crossReferences":{"PubChem":["104171107","11110758","11110759","124879235","144203630","170466659","26755647","90341790"],"Wikipedia":["Arecoline"],"drugbank":["DB04365"],"chEBI":["2814"]},"childChemblIds":["CHEMBL449209"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL76232","canonicalSmiles":"N[C@H](CCC(=O)O)C(=O)O","inchiKey":"WHUUTDBJXJRKMK-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-GLUTAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E620","Glutamic acid"],"crossReferences":{"PubChem":["11111223","11113411","144206603","26751650","26751651"],"drugbank":["DB02517"],"chEBI":["15966"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL83","canonicalSmiles":"CC/C(=C(\\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1","inchiKey":"NKANXQFJJICGDU-QPLCGJKRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TAMOXIFEN","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ICI-46474","ICI-47699","Mammaton","NSC-727681","Nolvadex","Novaldex","Soltamox","Tamoplex","Tamoxifen"],"crossReferences":{"DailyMed":["tamoxifen%20citrate"],"PubChem":["11113844","144208441","144210857","26752017","26752018","50104683","50104684","50104685","50104686","56320712","90340643"],"TG-GATEs":["54"],"Wikipedia":["Tamoxifen"],"drugbank":["DB00675"],"chEBI":["41774"]},"childChemblIds":["CHEMBL786"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0004248","EFO_0003869","EFO_1000403","EFO_0000637","EFO_0001075","EFO_1001901","MONDO_0007254","MONDO_0002087","EFO_0000305","HP_0000771","EFO_1000984","MONDO_0001187","MONDO_0002158","EFO_0000289","EFO_1001375","EFO_0000389","EFO_1000251","EFO_0000326","MONDO_0004976","MONDO_0004647","EFO_1000158","EFO_0001416","EFO_0000616","Orphanet_145","EFO_0000545","MONDO_0004658","MONDO_0008170","EFO_0009907","EFO_1001512","EFO_0000232","MONDO_0018848","EFO_0003843","EFO_0000660","MONDO_0008315","EFO_0000537","EFO_0009708","EFO_0000294","MONDO_0002691","MP_0001914","EFO_0000304","Orphanet_398934","Orphanet_98896","EFO_0004220","MONDO_0100096","EFO_0000311","EFO_0006861","EFO_0000764","Orphanet_774","MONDO_0011962","EFO_0000432","MONDO_0024880","EFO_0003833","EFO_0000519","EFO_0003922"],"count":54},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 4 approved and 46 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL831","canonicalSmiles":"CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1","inchiKey":"XJGVXQDUIWGIRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOXAPINE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adasuve","Loxitane intramuscular [as hydrochloride]","Loxitane-c oral suspension [as hydrochloride]"],"synonyms":["CL 62,362","CL-62362","Loxapac","Loxapine","Loxitane","SUM 3170","SUM-3170"],"crossReferences":{"PubChem":["50103874","50104024","50104025","50104026","90341467"],"Wikipedia":["Loxapine"],"drugbank":["DB00408"],"chEBI":["50841"]},"childChemblIds":["CHEMBL1201155","CHEMBL1201060"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["EFO_0005762","MONDO_0005277","MONDO_0005090","MONDO_0004979","EFO_0005407","EFO_0000341","EFO_0009963","EFO_0003768","EFO_0005230","HP_0000713"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 4 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL975","canonicalSmiles":"O=S(=O)([O-])CCS.[Na+]","inchiKey":"XOGTZOOQQBDUSI-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MESNA","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1098319","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mesna","Mesnex","Mistabron","Uromitexan"],"synonyms":["Coenzyme m sodium salt","D 7093","D-7093","Mesna","NSC-113891"],"crossReferences":{"DailyMed":["mesna"],"PubChem":["144208061","170464862","26748569","555156"],"Wikipedia":["Mesna"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for thrombocytopenia and has 49 investigational indications."}
{"id":"CHEMBL97972","canonicalSmiles":"O=[N+]([O-])c1c(Cl)cccc1-c1c[nH]cc1Cl","inchiKey":"QJBZDBLBQWFTPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRROLNITRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["52230","NSC-107654","Pyrrolnitrin"],"crossReferences":{"PubChem":["144206296","50125849"],"drugbank":["DB13603"],"chEBI":["32079"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL982","canonicalSmiles":"C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5","inchiKey":"WJBLNOPPDWQMCH-MBPVOVBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALMEFENE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Selincro"],"synonyms":["JF-1","JKB-121","Nalmefene","Nalmefene hydrochloride hydrate","Nalmetrene","ORF 1167","ORF 11676","ORF-1167","ORF-11676","Revex","SRD-174","SRD174"],"crossReferences":{"PubChem":["144204424","170465281","50103951","855608"],"Wikipedia":["Nalmefene"],"drugbank":["DB06230"],"chEBI":["7457"]},"childChemblIds":["CHEMBL1201152"],"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003086","EFO_0004319","EFO_1001249","EFO_0004699","EFO_0000274","MONDO_0007079","EFO_0005611"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for alcohol dependence and has 7 investigational indications."}
{"id":"CHEMBL99889","canonicalSmiles":"O=C(N[C@@H](Cc1ccc(F)cc1)C(=O)N1CCC(O)CC1)c1cc2cc(Cl)ccc2[nH]1","inchiKey":"YDCGVASFVACWKF-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-320626","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-320626"],"crossReferences":{"drugbank":["DB03383"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
